The Effect of Exparel on Post Operative Pain and Narcotic Use After Colon Surgery
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the effect of Exparel on pain control and patient
outcome after colon resection. The investigators will evaluate the clinical course of the
patients who receive exparel as compared to the patients who do not receive exparel. Exparel
is a 72 hour bupivacaine which is slowly released from lysosomes over the course of three
days. A long acting local anesthetic should provide better pain control than conventional
bupivacaine which has a 3.5 hour half-life.
Phase:
Phase 4
Details
Lead Sponsor:
Des Moines University
Collaborator:
Mercy Medical Center
Treatments:
Anesthetics Anesthetics, Local Bupivacaine Narcotics